Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline

Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline

Background: A new, effective anti-tuberculosis (TB) regimen containing bedaquiline (BDQ) and pyrifazimine (TBI-166) has been recommended for a phase IIb clinical trial. Preclinical drug-drug interaction (DDI) studies of the combination of BDQ and TBI-166 have been designed to support future clinical...

Full description

Saved in:
Bibliographic Details
Main Authors: Yangming Ding (Author), Haiting Liu (Author), Furun Wang (Author), Lei Fu (Author), Hui Zhu (Author), Shuang Fu (Author), Ning Wang (Author), Xiaomei Zhuang (Author), Yu Lu (Author)
Format: Book
Published: Frontiers Media S.A., 2023-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items